316 related articles for article (PubMed ID: 28417928)
1. Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.
Koizume S; Miyagi Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417928
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.
Ma Z; Zhang T; Wang R; Cheng Z; Xu H; Li W; Wang Y; Wang X
Int J Gynecol Cancer; 2011 May; 21(4):616-24. PubMed ID: 21543928
[TBL] [Abstract][Full Text] [Related]
3. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Yokota N; Koizume S; Miyagi E; Hirahara F; Nakamura Y; Kikuchi K; Ruf W; Sakuma Y; Tsuchiya E; Miyagi Y
Br J Cancer; 2009 Dec; 101(12):2023-9. PubMed ID: 19904262
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
Chanakira A; Westmark PR; Ong IM; Sheehan JP
Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
[TBL] [Abstract][Full Text] [Related]
5. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
6. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
Koizume S; Ito S; Yoshioka Y; Kanayama T; Nakamura Y; Yoshihara M; Yamada R; Ochiya T; Ruf W; Miyagi E; Hirahara F; Miyagi Y
Thromb Haemost; 2016 Jan; 115(2):299-310. PubMed ID: 26446354
[TBL] [Abstract][Full Text] [Related]
7. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
8. Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes.
Koizume S; Miyagi Y
Biomark Cancer; 2015; 7(Suppl 2):1-13. PubMed ID: 26396550
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation factors as inflammatory mediators.
Schoenmakers SH; Reitsma PH; Spek CA
Blood Cells Mol Dis; 2005; 34(1):30-7. PubMed ID: 15607697
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor mediates inflammation.
Chu AJ
Arch Biochem Biophys; 2005 Aug; 440(2):123-32. PubMed ID: 16036212
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.
Koizume S; Takahashi T; Yoshihara M; Nakamura Y; Ruf W; Takenaka K; Miyagi E; Miyagi Y
Thromb Haemost; 2019 Jul; 119(7):1058-1071. PubMed ID: 31055798
[TBL] [Abstract][Full Text] [Related]
13. Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer.
Koizume S; Ito S; Nakamura Y; Yoshihara M; Furuya M; Yamada R; Miyagi E; Hirahara F; Takano Y; Miyagi Y
Mol Cancer; 2015 Apr; 14():77. PubMed ID: 25879517
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor as a link between inflammation and coagulation.
Witkowski M; Landmesser U; Rauch U
Trends Cardiovasc Med; 2016 May; 26(4):297-303. PubMed ID: 26877187
[TBL] [Abstract][Full Text] [Related]
15. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
[TBL] [Abstract][Full Text] [Related]
16. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
Li Z; Block MS; Vierkant RA; Fogarty ZC; Winham SJ; Visscher DW; Kalli KR; Wang C; Goode EL
Tumour Biol; 2016 Oct; 37(10):13279-13286. PubMed ID: 27460076
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer.
Cohen JG; Prendergast E; Geddings JE; Walts AE; Agadjanian H; Hisada Y; Karlan BY; Mackman N; Walsh CS
Gynecol Oncol; 2017 Jul; 146(1):146-152. PubMed ID: 28501328
[TBL] [Abstract][Full Text] [Related]
18. The many faces of tissue factor.
Mackman N
J Thromb Haemost; 2009 Jul; 7 Suppl 1(Suppl 1):136-9. PubMed ID: 19630786
[TBL] [Abstract][Full Text] [Related]
19. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
Li T; Xue H; Guo Y; Guo K
Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
[TBL] [Abstract][Full Text] [Related]
20. 4.1N suppresses hypoxia-induced epithelial-mesenchymal transition in epithelial ovarian cancer cells.
Zhang L; Hu A; Li M; Zhang H; Ren C; An X; Liu C
Mol Med Rep; 2016 Jan; 13(1):837-44. PubMed ID: 26648170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
